Astagraf XL 5 mg 24HR Extended Release Oral Capsule
RxNorm 1431987
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1431987 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Astagraf XL 5 mg 24HR Extended Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
24 HR Astagraf 5 mg Extended Release Oral Capsule
(Atom ID: 6353503)
SBDPrescribable
Semantic Branded Drug (SBD):
24 HR tacrolimus 5 mg Extended Release Oral Capsule [Astagraf]
(Atom ID: 12369411)
SYPrescribable
Synonym (SY):
Astagraf XL 5 mg (as anhydrous tacrolimus) 24 HR Extended Release Oral Capsule
(Atom ID: 6358026)
SYPrescribable
Synonym (SY):
Astagraf XL 5 mg 24 HR Extended Release Oral Capsule
(Atom ID: 6357024)
PSNPrescribable
Prescribable Name (PSN):
Astagraf XL 5 mg 24HR Extended Release Oral Capsule
(Atom ID: 6359966)
Patient Education
Tacrolimus
Tacrolimus (Astagraf XL, Envarsus XR, Prograf) is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received a kidney transplant. Tacrolimus (Prograf) is also used along with other medications to prevent rejection in people who have received a liver or heart transplant. Tacrolimus is in a class of medications called immunosupressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ.
[Learn More]
* Please review the disclaimer below.